At Dörries Frank-Molnia & Pohlman, contentious proceedings often pertain to the pharmaceutical and mobile communications sectors. Simultaneously, the practice's forensic expertise is combined with an active prosecution practice, therefore enabling clients to receive holistic patent advice from one single source; here, objection and complaint proceedings are just as much part of the service portfolio as nullity and infringement proceedings. Biotechnology and pharmaceuticals matters are primarily handled by Hans Ulrich Dörries, Sandra Pohlman and Annette Hilgendorf, who made partner in February 2023, while David Molnia specialises in telecommunications and medical technology and Dominik Ho covers instructions in the physics, software and communications engineering industries. Other key figures in the team include Elisabeth Greiner (chemistry), Philipp Nordmeyer (applied physics, semiconductor technology, mechanical engineering among others), Oliver Schulz (lighting technology, medical technology, optics, telecommunications), René Okoampah (mechanical engineering, medical and mobile communications technology) and Michael Eder (chemistry and molecular biology).
Testimonials
Collated independently by Legal 500 research team.
'Powerful team that works at the highest level. The team not only understands the technology, but is extremely experienced in litigation and has perfected the interaction between nullity and infringement proceedings.'
'David Molnia: Outstanding. Extremely experienced. Always the right feel for really crucial points.'
Key clients
- Sonos
- InterDigital
Work highlights
- Advising and representing Interdigital in enforcing a patent portfolio against leading global electronics companies.
- Advising and representing Nokia in the enforcement of a patent portfolio against leading global electronics companies.